(Reuters) - Nearly a dozen countries resumed use of AstraZeneca’s COVID-19 shots on Friday as EU and British regulators said its benefits outweighed any risks. Reports of rare instances of blood clotting had temporarily halted inoculations.
(Reuters) - World Bank President David Malpass urged countries to enter contracts for vaccines now so they could get delivery schedules, saying it was vital to get started in more countries and work through more channels.
* The World Health Organization is working with the European Commission to coordinate vaccine donations for other countries on the continent, the head of its European office said.
WHO listed two versions of the AstraZeneca/Oxford COVID-19 vaccine for emergency use, giving the green light for these vaccines to be rolled out globally through COVAX. The vaccines are produced by AstraZeneca-SKBio (Republic of Korea) and the Serum Institute of India.